Novartis’ Glivec case in India delayed after judge disqualifies himself
This article was originally published in Scrip
Executive Summary
A Supreme Court judge set to hear a case involving Novartis' challenge against Section 3d, a controversial provision in India's patent law, has recused himself – a move that is now expected to require a new judge to hear the case at a later date.